Journal
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM
Volume 2, Issue 1, Pages 39-53Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/2042018810396750
Keywords
bevacizumab; diabetic macular edema; diabetic retinopathy; proliferative diabetic retinopathy; vision loss; vitrectomy
Categories
Ask authors/readers for more resources
Diabetic retinopathy is a common microvascular complication of prolonged diabetes. It is one of the leading causes of vision loss in working age adults and a significant source of morbidity. To reduce the incidence and severity of diabetic retinopathy, it is important to identify patients at risk and promptly implement intensive glycemic and hypertensive control. To date, there are many interventions that can limit moderate and severe vision loss in people with diabetes, including laser photocoagulation, vitrectomy surgery, and intravitreal pharmacological injections. This review aims to define the different stages of diabetic retinopathy and the important therapeutic advances developed to address the major causes of vision loss in each stage.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available